AKT1 and cancer: In AKT‐hyperactivated cancer cells, AKT directly phosphorylates TRPML1 at Ser343, inhibits K552 ubiquitination‐mediated degradation of TRPML1, promotes ferroptosis, and enhances sensitivity to radiotherapy and immunotherapy.